| Molecular Formula: | |
|---|---|
| Molecular Formula | C22H17ClN6O |
| Molecular Weight: | |
| Molecular Weight | 416.86 |
| COA: | |
| COA | Inquire |
| Targets: | |
| Targets | PI3K |
| Description: | |
| Description | The R isomer analogue of Duvelisib which is a high selective PI3K δ/γ inhibitor. |
| Purity: | |
|---|---|
| Purity | 95% |
| Appearance: | |
| Appearance | Powder |
| Synonyms: | |
| Synonyms | IPI-145 R enantiomer; IPI 145 R enantiomer; IPI145 R enantiomer; INK1197 R enantiomer; INK 1197 R enantiomer; INK-1197 R enantiomer |
| Solubility: | |
| Solubility | DMSO |
| Storage: | |
| Storage | -20ºC Freeze |
| MSDS: | |
| MSDS | Inquire |
| Application: | |
| Application | The R isomer analogue of Duvelisib which is a high selective PI3K δ/γ inhibitor. |
| Shelf Life: | |
| Shelf Life | As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly |
| Quantity: | |
|---|---|
| Quantity | Milligrams-Grams |
| InChIKey: | |
| InChIKey | SJVQHLPISAIATJ-CYBMUJFWSA-N |
| InChI: | |
| InChI | InChI=1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m1/s1 |
| Canonical SMILES: | |
| Canonical SMILES | CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5 |
GSK2636771
(CAS: 1372540-25-4)
GSK2636771 is an orally bioavailable, substituted benzimidazole inhibitor of the class I phosphoinositide 3-kinase (PI3K) beta isoform with potential antineopla...
ON 146040
(CAS: 1404231-34-0)
ON 146040 was highly potent in killing hematologic tumor cells with IC50 values in the 150 to 1,000 nM range. In biochemical testing, ON 146040 inhibited PI3K α...
NSC781406
(CAS: 1676893-24-5)
NSC781406 demonstrates potent PI3K inhibition (PI3Kα IC50=2.0 nM) and is a highly potent mTOR inhibitor, with reasonable liver microsome stability.
Duvelisib R enantiomer
(CAS: 1261590-48-0)
The R isomer analogue of Duvelisib which is a high selective PI3K δ/γ inhibitor.
3-Methyladenine
(CAS: 5142-23-4)
3-Methyladenine is an autophagy inhibitor that protects cerebellar granule cells (CGCs) from apoptosis following serum/potassium deprivation. 3-Methyladenine in...
AZD-8835
(CAS: 1620576-64-8)
AZD-8835 was selected as a clinical candidate for the treatment of PIK3CA-dependent cancers and is currently in phase I clinical trials. It is an orally bioavai...
PI3Kδ-IN-2
(CAS: 1702816-75-8)
PI3Kδ-IN-2 is a potent and selective inhibitor ofPI3Kδ (IC50= 6.4 M).
eCF309
(CAS: 2001571-40-8)
eCF309 is a potent and cell-permeable inhibitor of mTOR signaling (IC50 value 10 - 15 nM in vitro and in vivo) that exhibits >60-fold selectivity over PI3Ks. It...
AZD8186
(CAS: 1627494-13-6)
AZD 8186 is a selective PI3Kβ/δ inhibitor (IC50= 0.003 μM for PI3Kβ, and 0.017 μM for PI3Kδ) with potential antineoplastic activity. It shows no significant bin...
XL 765
(CAS: 1349796-36-6)
XL 765 is a PI3K inhibitor used for the treatment of cancers. It also suppresses DNA-PK and mTOR.
AMG319
(CAS: 1608125-21-8)
AMG319 is a potent and selective PI3Kδ inhibitor with IC50 of 18 nM, >47-fold selectivity over other PI3Ks. Phase 2.
Copanlisib
(CAS: 1032568-63-0)
Copanlisib is a phosphoinositide 3-kinase (PI3K) inhibitor with potential antineoplastic activity. BAY 80-6946 inhibits the activation of the PI3K signaling pat...
XL147
(CAS: 956958-53-5)
Pilaralisib is a Class 1 phosphatidylinositol 3 kinase (PI3K) family inhibitor. It is an orally bioavailable small molecule, targeting the class I PI3K family o...
SF2523
(CAS: 1174428-47-7)
SF2523 is a dual inhibitor of phosphatidylinositol 3-kinase and bromodomain-containing protein 4 with IC50 values of 34 nM, 158 nM, 9 nM, 241 nM and 280 nM for ...
IPI-549
(CAS: 1693758-51-8)
IPI-549, a dihydroisoquinolin derivative, has been found to be a phosphatidylinositol 3 kinase gamma inhibitor, could exhibit antineoplastic activity in solid t...
GDC-0084
(CAS: 1382979-44-3)
GDC-0084, a PI3K inhibitor, has been found to have probable antineoplastic effect and could pass blood-brain barrier with favourable penetration. It was just li...
RP-6530
(CAS: 1639417-53-0)
RP-6530, a purine derivative, has been found to be a PI3Kδ/γ inhibitor that could exhibit cytotoxicity in some lymphoma primary cells so that is significant in ...
AM-9635
(CAS: 1338483-10-5)
AM-9635 is a selective Phosphatidylinositol-3-kinase delta (PI3Kδ) inhibitor. AM-9635 exhibits good cellular potency (in vitro pAKT IC50 = 4.2 nM ). AM-9635 can...
